These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 9375827

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Carvedilol: a nonselective beta blocking agent with antioxidant properties.
    Book WM.
    Congest Heart Fail; 2002; 8(3):173-7, 190. PubMed ID: 12045386
    [Abstract] [Full Text] [Related]

  • 23. Effects of early carvedilol treatment and withdrawal on the development of hypertension and renal vascular narrowing.
    Kett MM, Denton KM, Boesen EI, Anderson WP.
    Am J Hypertens; 2004 Feb; 17(2):161-6. PubMed ID: 14751659
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Systematic review with meta-analysis: the haemodynamic effects of carvedilol compared with propranolol for portal hypertension in cirrhosis.
    Sinagra E, Perricone G, D'Amico M, Tinè F, D'Amico G.
    Aliment Pharmacol Ther; 2014 Mar; 39(6):557-68. PubMed ID: 24461301
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Carvedilol, an antihypertensive drug with antioxidant properties, protects against glycerol-induced acute renal failure.
    Singh D, Chander V, Chopra K.
    Am J Nephrol; 2003 Mar; 23(6):415-21. PubMed ID: 14573997
    [Abstract] [Full Text] [Related]

  • 30. Effects of carvedilol and propranolol on circulatory regulation and oxygenation in cirrhosis: a randomised study.
    Hobolth L, Bendtsen F, Hansen EF, Møller S.
    Dig Liver Dis; 2014 Mar; 46(3):251-6. PubMed ID: 24290869
    [Abstract] [Full Text] [Related]

  • 31. Carvedilol, a new beta-adrenoreceptor blocker, vasodilator and free-radical scavenger, exerts an anti-shock and endothelial protective effect in rat splanchnic ischemia and reperfusion.
    Christopher TA, Lopez BL, Yue TL, Feuerstein GZ, Ruffolo RR, Ma XL.
    J Pharmacol Exp Ther; 1995 Apr; 273(1):64-71. PubMed ID: 7714814
    [Abstract] [Full Text] [Related]

  • 32. The mechanism of carvedilol in experimental viral myocarditis.
    Yue-Chun L, Li-Sha G, Xue-Qiang G, Jia-Feng L.
    Curr Pharm Des; 2012 Apr; 18(12):1620-4. PubMed ID: 22443630
    [Abstract] [Full Text] [Related]

  • 33. The inhibitory effects of carvedilol against arrhythmias induced by coronary reperfusion in anesthetized rats.
    Takusagawa M, Komori S, Matsumura K, Osada M, Kohno I, Umetani K, Ishihara T, Sawanobori T, Ijiri H, Tamura K.
    J Cardiovasc Pharmacol Ther; 2000 Apr; 5(2):105-12. PubMed ID: 11150389
    [Abstract] [Full Text] [Related]

  • 34. Carvedilol, a new beta-adrenoceptor antagonist and vasodilator antihypertensive drug, inhibits superoxide release from human neutrophils.
    Yue TL, McKenna PJ, Ruffolo RR, Feuerstein G.
    Eur J Pharmacol; 1992 Apr 22; 214(2-3):277-80. PubMed ID: 1355437
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.